Founders

The company was founded by experienced professionals from the industry and world renowned scientists  capitalizing more than 60 years cumulative experience in wave physics, biomedical ultrasound and neuroscience.

Mickael Tanter, PhD

Research Professor of the French National Institute for Health and Medical Research, Institut Langevin, ESPCI, Paris France

Mickael Tanter is a research professor of the French National Institute for Health and Medical Research (INSERM) and distinguished professor of ESPCI Paris. He is heading the laboratory “Physics for Medicine” of the Langevin Institute (CNRS) at ESPCI Paris, France. He is also the director of the first INSERM Technology Research Accelerator created in 2016 and dedicated to Biomedical Ultrasound. He is a world-renowned expert in biomedical ultrasound and wave physics and authored more than 300 peer-reviewed papers and book chapters. He is the recipient of 45 international patents and co-invented several major innovations in Biomedical Ultrasound: Transient Elastography, Ultrafast Ultrasound and Shear Wave Elastography, functional Ultrasound imaging of brain activity and Super-Resolution Ultrasound. He received many national and international distinctions (among them the Honored Lecture of the Radiology Society of North America in 2012, the Grand Prize of the french Foundation of Medical Research in 2016 and the Carl Hellmuth Hertz Prize of IEEE Ultrasonics society in 2017). Co-founder of several MedTech companies in Biomedical Ultrasound (Supersonic Imagine, CardiaWave), he pioneered Neurofunctional Ultrasound with his team, a technology commercialized today by Iconeus.

Ludovic Lecointre, Pharm.D.

Chief Executive Officer

Ludovic Lecointre holds a Doctor of Pharmacy degree, with a primary background in chemistry.

During the first 15 years of his career, he held executive R&D positions at such pharmaceutical companies as Bristol-Myers Squibb, Parke-Davis, and Pfizer.

Over the next 12 years, he ran his own company (13 employees, €3.5 million/year in sales) in the field of health.

In parallel, he was appointed to the French national health agency as an expert on chemistry, manufacturing and controls (CMC) aspects for drug registration files.

In mid-2016, he created Iconeus. Since that date, he has acted as the CEO of this start-up dedicated to functional neuroimaging.

Zsolt Lenkei, MD, PhD

Research Director at the French National Institute of Health and Medical Research (INSERM)

Zsolt Lenkei graduated in 1992 from Semmelweis University Medical School in Budapest, Hungary. He obtained a PhD in Neurosciences of the University Pierre and Marie Curie in Paris in 1998, by working at the at the Chair de Médecine Experimentale of the College de France, Paris. After postdoc training at Montreal Neurological Institute of McGill University, Canada, he obtained a tenured researcher position at the French National Institute of Health and Medical Research (INSERM). He established his independent research team at the ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution). His was recently recruited as a senior team leader to the new Institute of Psychiatry and Neurosciences of Paris, INSERM U894. He is an internationally recognized specialist for the neuronal cell biology of cannabinoid receptors, as demonstrated by invited lectures world-wide and by his recent election as co-chair of Gordon Conference on Cannabinoids 2019. He mounted and coordinated several major French and European multiteam projects. He has also a proven track record to participate in interdisciplinary projects with physicists or chemists, yielding high-level publications and patents.

Mathieu Pernot, PhD

Research Director at the French National Institute of Health and Medical Research (INSERM)

Mathieu Pernot graduated in 2001 from the ESPCI (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) and obtained a PhD in Physics from the University Paris 7 in 2004. After a postdoc at Columbia university, he joined SuperSonic Imagine, in 2006, a startup company that developed the first clinical ultrafast ultrasound scanner. He is currently a research director at the French National Institute of Health and Medical Research (INSERM) and deputy director of Inserm U979 “Waves Physics for Medicine” at Langevin Institute, ESPCI, Paris, France. His research focuses on the development of wave physics for biomedical imaging and therapy including ultrafast ultrasound imaging, cardiovascular applications and non-invasive therapeutic ultrasound. He has been granted 26 patent families in the field of ultrasonic therapy and imaging and has published more than 110 peer-reviewed articles. He received in 2012 a prestigious award from the European Research Council (ERC starting grant) for his research on ultrafast imaging of the human heart and early diagnosis of heart failure. He and his co-authors received the IEEE UFFC Outstanding Paper Award in 2010 and 2016 and the Robert’s prize in 2015. He co-founded Cardiawave in 2014, a startup company developing the first clinical ultrasound device for non-invasive therapy of aortic calcified valves, who received the Therapeutic innovation prize of the foundation Béatrice Denys in 2015 and was laureate of the worldwide innovation challenge in 2017.  

Thomas Deffieux, PhD

Research Associate Professor at the French National Institute of Health and Medical Research (INSERM)

Thomas Deffieux obtained his PhD in Physics from the University Paris 7 in 2008 working on ultrasfast ultrasound imaging and shear wave elastography. After a postdoc at Columbia university dedicated to research on the Blood Brain Barrier using non invasive focused ultrasound and mcrobubbles, he joined the Langevin Institute in 2011, working on clinical trials of liver fibrosis and steatosis staging with shear wave spectroscopy and ultrafast imaging. 

Since 2013, he is currently associate research professor at the French National Institute of Health and Medical Research (INSERM) within Inserm U979 “Waves Physics for Medicine” at Langevin Institute, ESPCI, Paris, France. His research focuses on the development of wave physics for biomedical imaging and therapy including ultrafast ultrasound imaging, functional ultrasound imaging and non invasive ultrasound neuromodulation with innovative approaches.   

Bruno Osmanski, PhD

Chief Technical Officer at Iconeus

Bruno Osmanski graduated in 2010 from ESPCI Paris, a French Grande École for industrial physics and chemistry. That same year, he also obtained a Master’s degree in fundamental acoustics from Paris Diderot University. He went on to obtain his PhD in 2014, based on research performed at the Langevin Institute on ultrafast imaging for blood flow applications, including functional ultrasound imaging of the brain. As a postdoc, he joined the Neurophysiology & New Microscopies Laboratory (INSERM) for two years to study the mechanisms of neurovascular coupling using functional ultrasound, fMRI and two-photon imaging. His scientific career gave him practical and theoretical knowledge in both physics and neurosciences. He is now working as the CTO of Iconeus.